662
Views
24
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Efficacy and effects of palifermin for the treatment of oral mucositis in patients affected by acute lymphoblastic leukemia

, , , , &
Pages 820-827 | Received 18 Jul 2015, Accepted 03 Aug 2015, Published online: 20 Nov 2015

References

  • Ribera JM, Oriol A. Acute lymphoblastic leukemia in adolescents and young adults. Hematol Oncol Clin North Am 2009; 23: 1033–1042.
  • Greenlee RT, Murray T, Bolden S, et al. Cancer statistics, 2000. CA Cancer J Clin 2000; 50: 7–33.
  • Ponce-Torres E, Ruíz-Rodríguez Mdel S, Alejo-González F, et al. Oral manifestations in pediatric patients receiving chemotherapy for acute lymphoblastic leukemia. J Clin Pediatr Dent 2010; 34: 275–279.
  • Anirudhan D, Bakhshi S, Xess I, et al. Etiology and outcome of oral mucosal lesions in children on chemotherapy for acute lymphoblastic leukemia. Indian Pediatr 2008; 45: 47–52.
  • Levy-Polack MP, Sebelli P, Polack NL. Incidence of oral complications and application of a preventive protocol in children with acute leukemia. Spec Care Dentist 1998; 18: 189–193.
  • Lucchese A, Gherlone E. Prevalence of white-spot lesions before and during orthodontic treatment with fixed appliances. Eur J Orthod 2013; 35: 664–668.
  • Gandemer V, Le Deley MC, Dollfus C, et al. Pain task force of the SFCE. Multicenter randomized trial of chewing gum for preventing oral mucositis in children receiving chemotherapy. J Pediatr Hematol Oncol 2007; 29: 86–94.
  • Hernández-Fernández A, Oñate-Sánchez RE, Cabrerizo-Merino MC, et al. Influence of oral health on mucositis in patients undergoing hematopoietic progenitor cell transplantation (HPCT). Med Oral Patol Oral Cir Bucal 2012; 17: 94–101.
  • Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy induced stomatotoxicity. Oral Oncol 1998; 34: 39–43.
  • Currò M, Matarese G, Isola G, et al. Differential expression of transglutaminase genes in patients with chronic periodontitis. Oral Dis 2014; 20: 616–623.
  • Sonis ST, Elting LS, Keefe D, et al. Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology. Perspectives on cancer therapy-induced mucosal injury. Cancer 2004; 100: 1995–2025.
  • Elting LS, Cooksley C, Chambers M, et al. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2003; 98: 1531–1539.
  • Bellm LA, Epstein JB, Rose-Ped A, et al. Patient reports of complications of bone marrow transplantation. Support Care Cancer 2000; 8: 33–39.
  • Werner S. Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev 1998; 9: 153–165.
  • Farrell CL, Bready JV, Rex KL, et al. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 1998; 58: 933–939.
  • Dorr W, Heider K, Spekl K. Reduction of oral mucositis by palifermin (rHuKGF): dose-effect of rHuKGF. Int J Radiat Biol 2005; 81: 557–565.
  • Spielberger R, Stiff P, Bensinger W, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004; 351: 2590–2598.
  • Stiff PJ, Emmanouilides C, Bensinger WI, et al. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting. J Clin Oncol. 2006; 24: 5186–5193.
  • Martinez JM, Pereira D, Chacim S, et al. Mucositis care in acute leukemia and non-Hodgkin lymphoma patients undergoing high-dose chemotherapy. Support Care Cancer 2014; 22: 2563–2569.
  • Stiff PJ, Erder H, Bensinger WI, et al. Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT). Bone Marrow Transplant 2006; 37: 393–401.
  • Manji A, Tomlinson D, Ethier MC, et al. Psychometric properties of the Oral Mucositis Daily Questionnaire for child self-report and importance of mucositis in children treated with chemotherapy. Support Care Cancer 2012; 20: 1251–1258.
  • Srinivasan A, Kasow KA, Cross S, et al. Phase I study of the tolerability and pharmacokinetics of palifermin in children undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2012; 18: 1309–1314.
  • Greinix HT, Loddenkemper C, Pavletic SZ, et al. Diagnosis and staging of chronic graft-versus-host disease in the clinical practice. Biol Blood Marrow Transplant 2011; 17: 167–175.
  • Kowalski A, Enck P. Statistical methods: multiple significance tests and the Bonferroni procedure. Psychother Psychosom Med Psychol 2010; 60: 286–287.
  • Lehmann EL. Nonparametrics: statistical methods based on ranks. San Francisco: Holden-Day, Inc.; 1975:145.
  • Lino MD, Carvalho FB, Oliveira LR, et al. Laser phototherapy as a treatment for radiotherapy-induced oral mucositis. Braz Dent J 2011; 22: 162–165.
  • Lucchese A, Bertacci A, Chersoni S, et al. Primary enamel permeability: a SEM evaluation in vivo. Eur J Paediatr Dent 2012; 13: 231–235.
  • Pui CH, Campana D, Evans WE. Childhood acute lymphoblastic leukemia – current status and future perspectives. Lancet Oncol 2001; 2: 597–607.
  • Matarese G, Isola G, Anastasi GP, et al. Effects of the transforming growth factor Beta 1 and vascular endothelial growth factor expressions in the pathogenesis of periodontal disease. Eur J Inflamm 2013; 11: 479–488.
  • Sonis ST. Mucositis: the impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol 2009; 45: 1015–1020.
  • Parulekar W, Mackenzie R, Bjarnason G, et al. Scoring oral mucositis. Oral Oncol 1998; 34: 63–71.
  • Sonis ST. New thoughts on the initiation of mucositis. Oral Dis 2010; 16: 597–600.
  • Peterson DE. Research advances in oral mucositis. Curr Opin Oncol 1999; 11: 261–266.
  • Langner S, Staber PB. Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients. Bone Marrow Transplant 2008; 42: 275–279.
  • Schmidt E, Thoennissen NH, Rudat A, et al. Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis, Ann Oncol 2008; 19: 1644–1649.
  • Kobbe G, Bruns I, Schroeder T, et al. A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myeloma. Ann Oncol 2010; 21: 1898–1904.
  • Werner S, Smola H, Liao X, et al. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science 1994; 266: 819–822.
  • Potten CS, Booth D, Cragg NJ, et al. Cell kinetic studies in the murine ventral tongue epithelium: mucositis induced by radiation and its protection by pretreatment with keratinocyte growth factor (KGF). Cell Prolif 2002; 35(Suppl. 1): 32–47.
  • Zia-Amirhosseini P, Salfi M, Leese P, et al. Pharmacokinetics, pharmacodynamics, and safety assessment of palifermin (rHuKGF) in healthy volunteers. Clin Pharmacol Ther 2006; 79: 558–569.
  • Stiff P. Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant 2001; 27(Suppl. 2): S3–S11.
  • Dazzi C, Cariello A, Giovanis P, et al. Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study. Ann Oncol 2003; 14: 559–563.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.